First Financial Equity Corporation’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

First Financial Equity Corporation’s Portfolio AMPE Stock Details AMPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$15K	Buy	+61	New	+$16.4K	﹤0.01%	445

Other funds holding AMPE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NFG

Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return

FPCP

Fort Point Capital Partners San Francisco, California $825M AUM 16.14% 1-Year Est. Return

Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return

First Financial Equity Corporation's AMPE Position: Q1 2017 in Review

First Financial Equity Corporation opened a new position in Ampio Pharmaceuticals Inc. (AMPE) in Q1 2017: 61 shares worth $15K. The stake represents ﹤0.01% of the portfolio and ranks #445 among its holdings.

64 funds tracked by Wall St. Rank hold AMPE as of Q1 2017.

First Financial Equity Corporation held 61 shares of Ampio Pharmaceuticals Inc. worth $15K as of Q1 2017.
Ampio Pharmaceuticals Inc. was a new First Financial Equity Corporation position in Q1 2017.
Ampio Pharmaceuticals Inc. made up ﹤0.01% of First Financial Equity Corporation's portfolio in Q1 2017, its #445 holding.
64 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q1 2017.

Based on First Financial Equity Corporation's 13F filing for Q1 2017, filed 16 May 2017.